29 June 2021 | News
Promotion of DX through acquisition of data utilization skills including pharmaceutical-specific elements
Image credit- shutterstock.com
Japanese firms Chugai Pharmaceutical Co., Ltd. and ALBERT Inc, have jointly developed a data scientist training program for the pharmaceutical industry. The training program is part of CHUGAI DIGITAL ACADEMY, a digital talent training initiative started in April 2021, and aims to promote DX through the acquisition of data utilization skills including pharmaceutical-specific elements. It has been launched for Chugai Group employees in June 2021.
In addition to basic statistical analyses and programming techniques required to data scientists, this program enables the acquisition of knowledge and skills for data utilization specific to the pharmaceutical industry, such as clinical statistics and epidemiology fundamentals.
Chugai has set “Strengthen the digital platform” as one of the basic strategies of CHUGAI DIGITAL VISION 2030, and started CHUGAI DIGITAL ACADEMY in April 2021, a structured initiative for digital talent development.
ALBERT, with over 250 data scientists, has provided each industry with a more practical program, Data Scientist Training Support, by utilizing the expertise cultivated through in-house human resource training and having active data scientists as instructors. In addition, ALBERT has been working to develop industry-specific development programs.